Literature DB >> 23170294

The impact of beam angle configuration of intensity-modulated radiotherapy in the hepatocellular carcinoma.

Sung Hoon Kim1, Min Kyu Kang, Ji Woon Yea, Sung Kyu Kim, Ji Hoon Choi, Se An Oh.   

Abstract

PURPOSE: This treatment planning study was undertaken to evaluate the impact of beam angle configuration of intensity-modulated radiotherapy (IMRT) on the dose of the normal liver in hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: The computed tomography datasets of 25 patients treated with IMRT for HCC were selected. Two IMRT plans using five beams were made in each patient; beams with equidistance of 72° (Plan I), and beams with a 30° angle of separation entering the body near the tumor (Plan II). Both plans were generated using the same constraints in each patient. Conformity index (CI), homogeneity index (HI), gamma index, mean dose of the normal liver (Dmean_NL), Dmean_NL difference between the two plans, and percentage normal liver volumes receiving at least 10, 20, and 30 Gy (V10, V20, and V30) were evaluated and compared.
RESULTS: Dmean_NL, V10, and V20 were significantly better for Plan II. The Dmean_NL was significantly lower for peripheral (p = 0.001) and central tumors (p = 0.034). Dmean_NL differences between the two plans increased in proportion to gross tumor volume to normal liver volume ratios (p = 0.002). CI, HI, and gamma indices were not significantly different for the two plans.
CONCLUSION: The IMRT plan based on beams with narrow separations reduced the irradiated dose of the normal liver, which would allow radiation dose escalation for HCC.

Entities:  

Keywords:  Hepatocellular carcinoma; Intensity modulated radiation therapy; Radiation therapy

Year:  2012        PMID: 23170294      PMCID: PMC3496849          DOI: 10.3857/roj.2012.30.3.146

Source DB:  PubMed          Journal:  Radiat Oncol J        ISSN: 2234-1900


  15 in total

1.  A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note.

Authors:  I Paddick
Journal:  J Neurosurg       Date:  2000-12       Impact factor: 5.115

Review 2.  Radiotherapy for hepatocellular carcinoma: an overview.

Authors:  Sunil Krishnan; Laura A Dawson; Jinsil Seong; Yasuyuki Akine; Sam Beddar; Tina M Briere; Christopher H Crane; Francoise Mornex
Journal:  Ann Surg Oncol       Date:  2008-01-31       Impact factor: 5.344

3.  Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.

Authors:  Edgar Ben-Josef; Daniel Normolle; William D Ensminger; Suzette Walker; Daniel Tatro; Randall K Ten Haken; James Knol; Laura A Dawson; Charlie Pan; Theodore S Lawrence
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

4.  Local radiotherapy for patients with unresectable hepatocellular carcinoma.

Authors:  Won Park; Do Hoon Lim; Seung Woon Paik; Kwang Cheol Koh; Moon Seok Choi; Cheol Keun Park; Byung Chul Yoo; Jeong Eun Lee; Min Kyu Kang; Young Je Park; Hee Rim Nam; Yong Chan Ahn; Seung Jae Huh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-15       Impact factor: 7.038

Review 5.  The evolving role of radiation therapy in hepatocellular carcinoma.

Authors:  L A Dawson
Journal:  Cancer Radiother       Date:  2008-03-04       Impact factor: 1.018

Review 6.  Challenge and hope in radiotherapy of hepatocellular carcinoma.

Authors:  Jinsil Seong
Journal:  Yonsei Med J       Date:  2009-10-20       Impact factor: 2.759

7.  Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization.

Authors:  Mu-Tai Liu; Shih-Hai Li; Tieh-Chi Chu; Chang-Yao Hsieh; Ai-Yih Wang; Tung-Hao Chang; Chu-Ping Pi; Chia-Chun Huang; Jao-Perng Lin
Journal:  Jpn J Clin Oncol       Date:  2004-09       Impact factor: 3.019

8.  Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.

Authors:  Alyson McIntosh; Klaus D Hagspiel; Abdullah M Al-Osaimi; Patrick Northup; Stephen Caldwell; Carl Berg; J Fritz Angle; Curtis Argo; Geoffrey Weiss; Tyvin A Rich
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

9.  Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases.

Authors:  Jeong Won Jang; Chul Seung Kay; Chan Ran You; Chang Wook Kim; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon; Chi Wha Han; Hyun Suk Jung; Ihl Bong Choi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-27       Impact factor: 7.038

10.  High-dose radiotherapy with intensity-modulated radiation therapy for advanced hepatocellular carcinoma.

Authors:  Min Kyu Kang; Myung Se Kim; Sung Kyu Kim; Gi Won Ye; Heon Ju Lee; Tae Nyeun Kim; Jong Ryul Eun
Journal:  Tumori       Date:  2011 Nov-Dec
View more
  3 in total

Review 1.  Technical advances in external radiotherapy for hepatocellular carcinoma.

Authors:  Shin-Hyung Park; Jae-Chul Kim; Min Kyu Kang
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

2.  Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma.

Authors:  Eun Kyung Paik; Mi-Sook Kim; Chul Won Choi; Won Il Jang; Sung Hyun Lee; Sang Hyoun Choi; Kum Bae Kim; Dong Han Lee
Journal:  Radiat Oncol J       Date:  2015-09-30

3.  The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy.

Authors:  Bong Kyung Bae; Jae-Chul Kim
Journal:  Radiat Oncol J       Date:  2016-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.